☆ 4.7 Letter

Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors and Incident Type 2 Diabetes: A Systematic Review and Meta-analysis With Over 96,000 Patient-Years. Diabetes Care 2018;41:364-367

DIABETES CARE (2018)

Get Full Text
Add to Collection

Journal

DIABETES CARE
Volume 41, Issue 4, Pages E70-E71

Publisher

AMER DIABETES ASSOC
DOI: 10.2337/dci17-0069

Keywords

-

Categories

Endocrinology & Metabolism

Funding

  1. Brazilian National Research Council (CNPq)

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.